Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery

Objective: The objective of this clinical trial is to study the effectiveness of administering recombinant activated factor VII (rFVIIa) in reducing the amount of bleeding and the need for homologous blood and products transfusion in cardiac surgical coronary revascularization procedures done under...

Full description

Bibliographic Details
Main Author: Mohamed Essam Abdel-Meguid
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Saudi Journal of Anaesthesia
Subjects:
Online Access:http://www.saudija.org/article.asp?issn=1658-354X;year=2013;volume=7;issue=3;spage=301;epage=304;aulast=Abdel-Meguid